Found 5 matching trials
A Multicenter Study of rhFGF 18 in Patients With Knee Osteoarthritis Not Requiring Surgery PHASE1 Osteoarthritis (OA) is one of the most common diseases affecting the joints...
Show More Location
UMHAT "Sv. Ivan Rilski", Clinical Research Unit for Phase I
Learn More & Join Trial
A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the Knee PHASE2 This was a multicenter, randomized, double-blind, placebo-controlled, paral...
Show More Learn More & Join Trial
A Multicenter Trial of Sprifermin (AS902330 [Recombinant Human Fibroblast Growth Factor-18]) or Placebo After Microfracture Surgery for Cartilage Injury of the Knee PHASE2 This is a Phase 2, double-blind, multicenter, randomized, placebo-controlle...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of AS902330 (rhFGF-18) Administered Intra-articularly in Patients With Knee Primary Osteoarthritis Who Are Candidates for Total Knee Replacement PHASE1 Osteoarthritis (OA) is one of the most common diseases affecting the joints...
Show More Location
UMHAT "Sv. Ivan Rilski", Clinical Research Unit for Phase I
Learn More & Join Trial
Sprifermin (AS902330) in Cartilage Injury Repair (CIR) PHASE2 Several people all over the world suffer from cartilage injuries in the kne...
Show More Location
Please contact the Merck KGaA Communication Center
Learn More & Join Trial